Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method

Christopher G. Thomas, Johannes J. Krupp, Elena E. Bagley, Reginald Bauzon, Stephen F. Heinemann, Bryce Vissel, Gary Westbrook

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Several forms of macroscopic N-methyl-D-aspartate (NMDA) receptor desensitization affect the amplitude and duration of postsynaptic responses. In addition to its functional significance, desensitization provides one means to examine the conformational coupling of ligand binding to channel gating. Segments flanking the ligand binding domain in the extracellular N terminus of the NMDA receptor NR2 subunit influence the glycine-independent form of desensitization. The NR2A pre-M1 region, the linker between the glutamate binding domain and the channel pore, plays a critical role in desensitization. Thus, we used the substituted-cysteine accessibility method to scan the accessibility of residues in the pre-M1 region and the first transmembrane domain (M1) of NR2A. Cysteine mutants were expressed with NR1 in human embryonic kidney 293 cells and were assayed by whole-cell recording. With activation of the receptor by glutamate and glycine, only a single mutant, V557C, which is located at the beginning of M1, led to irreversible inhibition by the methanethiosulfonate derivative methanethiosulfonate ethyltrimethylammonium (MTSET). The NR2 ligand glutamate was insufficient on its own to induce modification of V557C by MTSET, suggesting that the change in accessibility required channel gating. The rate of MTSET modification of the homologous residue on NR1 (NR1-1aL562C/NR2A) was much slower than V557C. We also substituted cysteine in the V557 site of mutant subunits that exhibit either enhanced or reduced desensitization. Modification by MTSET correlated with the degree of desensitization for these subunits, suggesting that V557C is a sensitive detector of desensitization gating.

Original languageEnglish (US)
Pages (from-to)1296-1303
Number of pages8
JournalMolecular Pharmacology
Volume69
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

N-Methyl-D-Aspartate Receptors
Cysteine
Ligands
Glutamic Acid
Glycine Receptors
Glutamate Receptors
Patch-Clamp Techniques
Glycine
methanethiosulfonate
Kidney
trimethylethylammonium

ASJC Scopus subject areas

  • Pharmacology

Cite this

Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method. / Thomas, Christopher G.; Krupp, Johannes J.; Bagley, Elena E.; Bauzon, Reginald; Heinemann, Stephen F.; Vissel, Bryce; Westbrook, Gary.

In: Molecular Pharmacology, Vol. 69, No. 4, 04.2006, p. 1296-1303.

Research output: Contribution to journalArticle

Thomas, Christopher G. ; Krupp, Johannes J. ; Bagley, Elena E. ; Bauzon, Reginald ; Heinemann, Stephen F. ; Vissel, Bryce ; Westbrook, Gary. / Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method. In: Molecular Pharmacology. 2006 ; Vol. 69, No. 4. pp. 1296-1303.
@article{dc8b24f420fe4a4cad87a445da22063e,
title = "Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method",
abstract = "Several forms of macroscopic N-methyl-D-aspartate (NMDA) receptor desensitization affect the amplitude and duration of postsynaptic responses. In addition to its functional significance, desensitization provides one means to examine the conformational coupling of ligand binding to channel gating. Segments flanking the ligand binding domain in the extracellular N terminus of the NMDA receptor NR2 subunit influence the glycine-independent form of desensitization. The NR2A pre-M1 region, the linker between the glutamate binding domain and the channel pore, plays a critical role in desensitization. Thus, we used the substituted-cysteine accessibility method to scan the accessibility of residues in the pre-M1 region and the first transmembrane domain (M1) of NR2A. Cysteine mutants were expressed with NR1 in human embryonic kidney 293 cells and were assayed by whole-cell recording. With activation of the receptor by glutamate and glycine, only a single mutant, V557C, which is located at the beginning of M1, led to irreversible inhibition by the methanethiosulfonate derivative methanethiosulfonate ethyltrimethylammonium (MTSET). The NR2 ligand glutamate was insufficient on its own to induce modification of V557C by MTSET, suggesting that the change in accessibility required channel gating. The rate of MTSET modification of the homologous residue on NR1 (NR1-1aL562C/NR2A) was much slower than V557C. We also substituted cysteine in the V557 site of mutant subunits that exhibit either enhanced or reduced desensitization. Modification by MTSET correlated with the degree of desensitization for these subunits, suggesting that V557C is a sensitive detector of desensitization gating.",
author = "Thomas, {Christopher G.} and Krupp, {Johannes J.} and Bagley, {Elena E.} and Reginald Bauzon and Heinemann, {Stephen F.} and Bryce Vissel and Gary Westbrook",
year = "2006",
month = "4",
doi = "10.1124/mol.105.017350",
language = "English (US)",
volume = "69",
pages = "1296--1303",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method

AU - Thomas, Christopher G.

AU - Krupp, Johannes J.

AU - Bagley, Elena E.

AU - Bauzon, Reginald

AU - Heinemann, Stephen F.

AU - Vissel, Bryce

AU - Westbrook, Gary

PY - 2006/4

Y1 - 2006/4

N2 - Several forms of macroscopic N-methyl-D-aspartate (NMDA) receptor desensitization affect the amplitude and duration of postsynaptic responses. In addition to its functional significance, desensitization provides one means to examine the conformational coupling of ligand binding to channel gating. Segments flanking the ligand binding domain in the extracellular N terminus of the NMDA receptor NR2 subunit influence the glycine-independent form of desensitization. The NR2A pre-M1 region, the linker between the glutamate binding domain and the channel pore, plays a critical role in desensitization. Thus, we used the substituted-cysteine accessibility method to scan the accessibility of residues in the pre-M1 region and the first transmembrane domain (M1) of NR2A. Cysteine mutants were expressed with NR1 in human embryonic kidney 293 cells and were assayed by whole-cell recording. With activation of the receptor by glutamate and glycine, only a single mutant, V557C, which is located at the beginning of M1, led to irreversible inhibition by the methanethiosulfonate derivative methanethiosulfonate ethyltrimethylammonium (MTSET). The NR2 ligand glutamate was insufficient on its own to induce modification of V557C by MTSET, suggesting that the change in accessibility required channel gating. The rate of MTSET modification of the homologous residue on NR1 (NR1-1aL562C/NR2A) was much slower than V557C. We also substituted cysteine in the V557 site of mutant subunits that exhibit either enhanced or reduced desensitization. Modification by MTSET correlated with the degree of desensitization for these subunits, suggesting that V557C is a sensitive detector of desensitization gating.

AB - Several forms of macroscopic N-methyl-D-aspartate (NMDA) receptor desensitization affect the amplitude and duration of postsynaptic responses. In addition to its functional significance, desensitization provides one means to examine the conformational coupling of ligand binding to channel gating. Segments flanking the ligand binding domain in the extracellular N terminus of the NMDA receptor NR2 subunit influence the glycine-independent form of desensitization. The NR2A pre-M1 region, the linker between the glutamate binding domain and the channel pore, plays a critical role in desensitization. Thus, we used the substituted-cysteine accessibility method to scan the accessibility of residues in the pre-M1 region and the first transmembrane domain (M1) of NR2A. Cysteine mutants were expressed with NR1 in human embryonic kidney 293 cells and were assayed by whole-cell recording. With activation of the receptor by glutamate and glycine, only a single mutant, V557C, which is located at the beginning of M1, led to irreversible inhibition by the methanethiosulfonate derivative methanethiosulfonate ethyltrimethylammonium (MTSET). The NR2 ligand glutamate was insufficient on its own to induce modification of V557C by MTSET, suggesting that the change in accessibility required channel gating. The rate of MTSET modification of the homologous residue on NR1 (NR1-1aL562C/NR2A) was much slower than V557C. We also substituted cysteine in the V557 site of mutant subunits that exhibit either enhanced or reduced desensitization. Modification by MTSET correlated with the degree of desensitization for these subunits, suggesting that V557C is a sensitive detector of desensitization gating.

UR - http://www.scopus.com/inward/record.url?scp=33645096210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645096210&partnerID=8YFLogxK

U2 - 10.1124/mol.105.017350

DO - 10.1124/mol.105.017350

M3 - Article

C2 - 16377766

AN - SCOPUS:33645096210

VL - 69

SP - 1296

EP - 1303

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 4

ER -